Category: Our News

Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers

May 15th – 2020 – CQDM congratulates Theratechnologies and UQAM’s Professor Borhane Annabi for the positive results presented at the Virtual Annual Meeting II of the American Association for Cancer Research (AACR), particularly those obtained with its docetaxel-peptide conjugate TH-1902 for the treatment of triple-negative breast cancer. These are very encouraging results! To read Theratechnologies press…

Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D

Quebec City, Quebec, May 5th, 2020 – The biopharmaceutical research consortium CQDM and Medicago R&D  are proud to announce today the funding of a research project that will allow the Quebec City-based company to increase the competitiveness of its vaccine production platform and confirm its position as leader in the biopharmaceutical industry in Canada. Through CQDM,…

Pre-launch of a new call for proposals in June 2020: discover the latest updates!

Fonds d’accélération des collaborations en santé (Health Collaboration Acceleration Fund) May 27th 2020 – To stimulate economic recovery in the life sciences sector, the Government of Quebec is making changes to the Fonds d’accélération des collaborations en santé (FACS) and inviting actors of the ecosystem to collaborate by launching ambitious projects that meet the practical needs…

CQDM welcomes Zymeworks as a new member of CQDM’s biopharmaceutical consortium

Montreal, February 27, 2020 – CQDM is pleased to welcome Zymeworks Inc. as a new member of its biopharmaceutical research consortium established to identify and invest in highly innovative biopharmaceutical research projects in Quebec and Canada with the ultimate goal of enabling the development of better treatments for patients. As a CQDM member, Zymeworks will…

2nd Annual Gordon Shore Prize – Call for Proposal to Private Companies

Private companies based in Quebec with biopharmaceutical-related activities are invited to propose postdoctoral internship positions for new doctoral graduates, future awardees of the Gordon Shore Prize. Award sponsors, CQDM, Diazon Pharmaceuticals and Mitacs will finance 50% of these postdoctoral internships. The company must agree to pay the other half of the new graduate’s salary. The application…

Project funded through CQDM will explore potential of Fusion Genomics’ ONETest™ to improve diagnosis of respiratory tract infections

We’re delighted to announce that Fusion Genomics has been awarded $1 million to conduct a prospective clinical study evaluating its product: ONETest™. The project will be funded through our Quantum Leap program with support from Merck and will explore the improvement for diagnosis of respiratory tract infections. Fusion Genomics ONETest™ is a highly sensitive, cost-effective…

Postponed deadline to submit a SynergiQc project

April 1st, 2020 – Update Regarding the Current SynergiQc Call for Projects – CQDM wishes to confirm to the Quebec biopharmaceutical community that its current SynergiQc Call for projects is maintained. More than ever, it is crucial to promote the discovery and development of safe products in order to prevent, diagnose and treat diseases, related or not…

CQDM and the Canadian Cancer Society commend Theratechnologies and UQAM for their success in developing a new therapy against the most aggressive form of breast cancer

Montréal, December 18, 2019 – CQDM congratulates Theratechnologies for reporting positive results on TH-1902, a docetaxel conjugate for the treatment of triple-negative breast cancer (TNBC), during the prestigious San Antonio Breast Cancer Symposium held on December 10-14 in San Antonio (Texas, USA). Theratechnologies also announced that the Food and Drug Administration (FDA) has approved the…

2nd Annual Gordon Shore Prize – Postdoctoral Internships in the Biopharmaceutical Industry

Presented by CQDM, Diazon Pharmaceuticals and Mitacs, the Gordon Shore Prize is awarded to new graduates whose doctoral thesis demonstrated their research excellence in the life science field. A 6-month postdoctoral internship of $24,000 will be offered to each of the awardees by the participating Quebec-based companies: Feldan Therapeutics, Kisoji Biotechnology, Ovensa Innovations and Repare…